A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death

Por um escritor misterioso

Descrição

A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
Journal of the American Chemical Society
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
Molecules, Free Full-Text
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
IJMS, Free Full-Text
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
Frontiers Publishing Partnerships
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
Future Pharmacology, Free Full-Text
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
Francisco Martínez-Peña's research works
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
Meta analysis of bioactive compounds, miRNA, siRNA and cell death
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
Membranes, Free Full-Text
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
PDF) The solute carrier SLC35F2 enables YM155-mediated DNA damage
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein  Kinase 2 to Induce Brain Cancer Cell Death
Microparticles: biogenesis, characteristics and intervention
de por adulto (o preço varia de acordo com o tamanho do grupo)